nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial
|
Andries, Alin |
|
2015 |
25 |
5 |
p. 247-252 6 p. |
artikel |
2 |
Crosstalk between the TNF and IGF pathways enhances NF-κB activation and signaling in cancer cells
|
Li, Shun |
|
2015 |
25 |
5 |
p. 253-261 9 p. |
artikel |
3 |
editorial Board
|
|
|
2015 |
25 |
5 |
p. i- 1 p. |
artikel |
4 |
Elevated insulin-like growth factor 2 expression may contribute to the hypermuscular phenotype of myostatin null mice
|
Clark, Daniel L. |
|
2015 |
25 |
5 |
p. 207-218 12 p. |
artikel |
5 |
Instability of IGF–IGFBP complex as a cause of the different performance of serum and EDTA-plasma after storage: EDTA-plasma is preferable for evaluating bioactive IGF especially in the mouse
|
Setoyama, Takeshi |
|
2015 |
25 |
5 |
p. 227-231 5 p. |
artikel |
6 |
More concerns and stronger beliefs about the necessity of medication in patients with acromegaly are associated with negative illness perceptions and impairment in quality of life
|
Andela, Cornelie D. |
|
2015 |
25 |
5 |
p. 219-226 8 p. |
artikel |
7 |
Pappa2 deletion alters IGFBPs but has little effect on glucose disposal or adiposity
|
Christians, Julian K. |
|
2015 |
25 |
5 |
p. 232-239 8 p. |
artikel |
8 |
Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations
|
Ciresi, A. |
|
2015 |
25 |
5 |
p. 240-246 7 p. |
artikel |
9 |
Status of long-acting-growth hormone preparations — 2015
|
Høybye, Charlotte |
|
2015 |
25 |
5 |
p. 201-206 6 p. |
artikel |
10 |
Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache
|
Marina, Djordje |
|
2015 |
25 |
5 |
p. 262-267 6 p. |
artikel |